首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Clinical and translational medicine

缩写:

ISSN:2001-1326

e-ISSN:2001-1326

IF/分区:6.8/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引2648
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Xianghui Zheng,Yunqi Li,Peiyao Wang et al. Xianghui Zheng et al.
Background: Chronic psychological stress drives neuroimmune crosstalk and accelerates atherosclerosis progression. Physical exercise confers broad health benefits and is associated with reduced inflammation. However, the ...
Shuang Yang,Rui Fu,Xiaoxiao Ren et al. Shuang Yang et al.
Background: Vascular smooth muscle cell (VSMC) phenotype switching plays a significant role in the pathogenesis of atherosclerosis (AS). However, the subtypes of VSMC transdifferentiation and their impact on AS progressio...
Ke Zhen,Zhiyong Du,Pengcheng Wang et al. Ke Zhen et al.
Background: Ascending thoracic aortic aneurysm (ATAA) is a fatal vascular disease characterized by immune dysregulation. However, the cellular composition, spatial localization, and functional diversity of immune cells in...
Junshu Li,Wencheng Zhou,Ying Cen et al. Junshu Li et al.
Extracellular vesicles (EVs) have become key mediators of intercellular communication in melanoma cells and significantly affect disease progression by delivering bioactive molecules. EVs are loaded with a wide variety of biomolecule carrie...
Zhenhua Liu,Bo Chen,Tao Dai et al. Zhenhua Liu et al.
Background: A multi-centre, 2-part, phase II study assessed adding rezvilutamide (a novel androgen receptor antagonist) to docetaxel in abiraterone-refractory, metastatic castration-resistant prostate cancer (mCRPC) patie...
Jun Xiao,Jianghua Wu,Fengliu Deng et al. Jun Xiao et al.
Tumour metabolic modulation represents a promising adjuvant therapeutic strategy for cancers, including colorectal cancer (CRC). Dapagliflozin, a clinically approved sodium‒glucose cotransporter 2 (SLC5A2/SGLT2) inhibitor, has attracted co...
Maoguang Ma,Mingdian Wang,Yufei Yang et al. Maoguang Ma et al.
Background: Current therapeutic outcomes for advanced colorectal cancer (CRC) remain suboptimal, and chemotherapy-based regimens continue to be the mainstay of treatment. Circular RNAs (circRNAs) can serve as templates fo...